Search Results 1881-1890 of 4035 for Solid
The purpose of this study is to evaluate ALPN-202 with PD-1 inhibition to treat adults with advanced solid tumors or lymphoma. A Study to Create a Registry ...
... Solid Tumors version 1.1 (RECIST 1.1) after initial treatment. Combination Therapy of Acalabrutinib, Venetoclax and Durvalumab to Treat Richter ...
... solid and liquid cancers; Connecting these patients with appropriate rehabilitation services. This multisite study involves 15 randomized clusters of patients ...
Measurable disease by any imaging modality as defined by Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria in at least one site not previously ...
... Solid-State Detector Between Men and Women in a Large International Multicenter Study. Circ Cardiovasc Imaging. 2022 Jun; 15 (6):e012741 Epub 2022 June 21
... Solid Tumors (RECIST) target lesions, unless there are no other lesions accessible; Microbiology Susceptibility Subcategory (MSS) tumor as documented by ...
Depending on the type of anesthesia you'll have, you may need to avoid eating solid foods eight hours before starting your procedure. Arrange for a ride ...
Patients must have measurable disease per Response Evaluation Criteria in Solid Tumors (RECIST) version (v)1.1 by computer tomography (CT) scan or magnetic ...
History of stem cell transplantation, bone marrow transplantation, chimeric antigen receptor T-cell therapy, or solid organ transplantation. Women who are ...
... solid tumors. It is necessary that ctDNA test results are linked to clinical outcomes in order to demonstrate clinical validity for recurrence detection and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!